Farallon Capital Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Farallon Capital Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-220,000	Closed	-$21.3M	–	128
2019 Q3	$21.3M	Sell	220,000 -550,000	-71%	-$55.1M	0.16%	74
2019 Q2	$78.8M	Sell	770,000 -50,000	-6%	-$5.4M	0.51%	44
2019 Q1	$93.4M	Buy	+820,000	New	+$60.3M	0.7%	40

Farallon Capital Management's ONCE Position: Q4 2019 in Review

Farallon Capital Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 220,000 shares — an estimated $21.3M sold.

Farallon Capital Management first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $93.4M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Farallon Capital Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Farallon Capital Management sold 220,000 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $21.3M.
Farallon Capital Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
Farallon Capital Management's Spark Therapeutics, Inc. Common Stock position peaked at $93.4M in Q1 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Farallon Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.